Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack
- PMID: 2155179
- PMCID: PMC1385595
Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack
Abstract
The effects of non-lethal complement attack on cultured human rheumatoid synovial cells have been investigated by measuring a variety of parameters. Within 3-4 min of initiating non-lethal complement membrane attack there was a rise in reactive oxygen metabolite release from cultured synovial cells, which slowly returned to basal levels over a period of 45 min. The response was dependent on the formation of the complete C5b-9 complex. Prostaglandin E2 was also released during non-lethal attack in a biphasic manner, an early phase of release occurring within the first hour and a second, larger phase commencing at 4 hr and rising to levels of over 1000 ng/10(6) cells at 24 hr, compared to control levels at this time of less than 100 ng/10(6) cells. This response was dependent on the formation of the C5b-8 complex but did not require C9. Removal of extracellular calcium reduced release of prostaglandin E2 to background levels, and inclusion of an inhibitor of protein synthesis abolished the second phase of release but not the first phase. Non-lethal attack caused release of small amounts of leukotriene B4 but no detectable release of tumour necrosis factor.
Similar articles
-
Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.Immunology. 1990 Nov;71(3):312-6. Immunology. 1990. PMID: 2269468 Free PMC article.
-
In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium.Clin Exp Immunol. 1988 Sep;73(3):467-72. Clin Exp Immunol. 1988. PMID: 3208453 Free PMC article.
-
Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.J Rheumatol. 2002 Mar;29(3):546-53. J Rheumatol. 2002. PMID: 11908571
-
The complement attack phase: control of lysis and non-lethal effects of C5b-9.Immunopharmacology. 1992 Sep-Oct;24(2):107-17. doi: 10.1016/0162-3109(92)90017-7. Immunopharmacology. 1992. PMID: 1473962 Review. No abstract available.
-
Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?Ann Rheum Dis. 1995 Jul;54(7):533-4. doi: 10.1136/ard.54.7.533. Ann Rheum Dis. 1995. PMID: 7668891 Free PMC article. Review. No abstract available.
Cited by
-
Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.Clin Exp Immunol. 1991 May;84(2):250-5. Clin Exp Immunol. 1991. PMID: 2025952 Free PMC article.
-
Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.Immunology. 1990 Nov;71(3):308-11. Immunology. 1990. PMID: 1702747 Free PMC article.
-
The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.Am J Pathol. 1996 Sep;149(3):953-61. Am J Pathol. 1996. PMID: 8780399 Free PMC article.
-
Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.Immunology. 1990 Nov;71(3):312-6. Immunology. 1990. PMID: 2269468 Free PMC article.
-
Complement and periodontitis.Biochem Pharmacol. 2010 Dec 15;80(12):1992-2001. doi: 10.1016/j.bcp.2010.06.017. Epub 2010 Jun 23. Biochem Pharmacol. 2010. PMID: 20599785 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous